UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057891 |
|---|---|
| Receipt number | R000066166 |
| Scientific Title | Investigation of the distribution of urinary 11-ketoethiocholanolone glucuronide concentrations in Non-diabetic subjects (exploratory clinical study) |
| Date of disclosure of the study information | 2025/05/17 |
| Last modified on | 2025/05/21 14:30:13 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of the distribution of urinary 11-ketoethiocholanolone glucuronide concentrations in Non-diabetic subjects (exploratory clinical study)
Acronym
Investigation of the distribution of urinary 11-ketoethiocholanolone glucuronide concentrations in Non-diabetic subjects (exploratory clinical study)
Scientific Title
Investigation of the distribution of urinary 11-ketoethiocholanolone glucuronide concentrations in Non-diabetic subjects (exploratory clinical study)
Scientific Title:Acronym
Investigation of the distribution of urinary 11-ketoethiocholanolone glucuronide concentrations in Non-diabetic subjects (exploratory clinical study)
Region
| Japan |
Condition
Condition
Non- diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the distribution of urinary 11-ketoethiocholanolone glucuronide (11-KG) concentrations in Non-diabetic subjects.
Basic objectives2
Others
Basic objectives -Others
Shape of blood glucose curve obtained from 75g OGTT
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
urinary 11-ketoethiocholanolone glucuronide (11-KG) concentrations
Key secondary outcomes
Shape of blood glucose curve obtained from 75g OGTT
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
A 75 g OGTT will be performed on subjects with urinary 11-KG concentrations in the lower quartile.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Not diagnosed with diabetes mellitus.
2. 20 years of age or older.
3. Have given their free and voluntary written consent to participate in this clinical research.
Key exclusion criteria
1.Those taking drugs that affect glucose metabolism (steroids, immunosuppressants, beta-blockers).
2.Those with a history of malignancy of the kidney, ureter, bladder, or urethra.
3.Those with a history of endocrine disorders.
4.Pregnant or possibly pregnant.
5.Lactating mothers.
6.Known hypersensitivity to the study drug (Traylan G Solution 75g).
7.Any other cases in which the principal investigator determines that the subject is not suitable for the study.
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Kazuhiko |
| Middle name | |
| Last name | Sakaguchi |
Organization
Kobe university
Division name
Department of General Medicine
Zip code
650-0017
Address
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
TEL
078-382-5861
kzhkskgc@med.kobe-u.ac.jp
Public contact
Name of contact person
| 1st name | Kazuhiko |
| Middle name | |
| Last name | Sakaguchi |
Organization
Kobe university
Division name
Department of General Medicine
Zip code
650-0017
Address
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
TEL
078-382-5861
Homepage URL
kzhkskgc@med.kobe-u.ac.jp
Sponsor or person
Institute
Kobe university
Institute
Department
Personal name
Funding Source
Organization
Others
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Intervention research ethics revies committee
Address
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
Tel
0783826669
kainyu@med.kobe-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 05 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 05 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 05 | Month | 17 | Day |
Last modified on
| 2025 | Year | 05 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066166
